Ticker Scorecard - ERAS Basics Company: Erasca, Inc. IPO Date: July 16, 2021 Sector: Healthcare Industry: Biotech Market Cap: $398.65M Activated in VL: True Average Daily Range Avg Daily Range: $0.23 | 3.54% Avg Daily Range (30 D): $0.07 | 3.63% Avg Daily Range (90 D): $0.08 | 3.33% Institutional Daily Volume Avg Daily Volume: .8M Avg Daily Volume (30 D): 1.22M Avg Daily Volume (90 D): 1.19M Trade Size Avg Trade Size (Sh.): 130 Avg Trade Size (Sh.) (30 D): 170 Avg Trade Size (Sh.) (90 D): 158 Institutional Trades Total Inst.Trades: 406 Avg Inst. Trade: $2.01M Avg Inst. Trade (30 D): $.86M Avg Inst. Trade (90 D): $1.14M Avg Inst. Trade Volume: .41M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.87M Avg Closing Trade (30 D): $3.35M Avg Closing Trade (90 D): $.92M Avg Closing Volume: 543.7K     News Jan 31, 2025 @ 1:00 PM Erasca to Present at the Guggenheim Securities SMI... Source: N/A Dec 26, 2024 @ 4:26 PM Oncology in Focus: How Emerging Therapies Are Resh... Source: Prnewswire Nov 5, 2024 @ 1:00 PM Erasca to Present at Upcoming Investor Conferences... Source: N/A Jun 4, 2024 @ 1:55 PM Should You Buy Erasca, Inc. (ERAS) After Golden Cr... Source: Zacks Equity Research May 21, 2024 @ 8:05 PM Erasca Announces Closing of Underwritten Offering ... Source: Erasca, Inc. Financials   TTM Q2 2024 Q1 2024 Basic EPS $-.11 $-.29 $-.23 Diluted EPS $-.11 $-.29 $-.23 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -31.2M $ -63.2M $ -35.02M Operating Income / Loss $ -37.24M $ -67.78M $ -38.85M Cost of Revenue $ $ $ Net Cash Flow $ -103.92M $ 96.08M $ -16.35M PE Ratio